Inhibition of lung natural killer cell activity by smoking: the role of alveolar macrophages. 2001

M Takeuchi, and S Nagai, and A Nakajima, and M Shinya, and C Tsukano, and H Asada, and K Yoshikawa, and M Yoshimura, and T Izumi
Department of Biotechnology, Faculty of Engineering, Kyoto Sangyo University, Kyoto, Japan. mtakex@cc.kyoto-u.ac.jp

BACKGROUND It is known that natural killer (NK) cell activity in the lung of smokers (SM) is lower than in non-smokers (NS). However, little is known about the underlying mechanisms. OBJECTIVE The purpose of this work was to investigate the mechanisms of the inhibition of NK cell activity by alveolar macrophages (AM) in SM. METHODS Lung effector cells and AM were obtained using bronchoalveolar lavage. The NK cell activity was assayed by 51Cr release method after incubation of 4 and 24 h, using K562 as target cell. AM were added at a concentration of 25% to effector cells. RESULTS Following 24-hour culture, NK cell activity significantly increased in the NS but not in the SM. Lung NK cell activity was significantly augmented by interleukin-2 in the NS but not in the SM. Addition of AM to the NK cell preparation from SM exerted a significantly greater suppressive effect on autologous blood NK cell activity than in the NS. Indomethacin, catalase or thiourea did not prevent AM-mediated suppression of NK cell activity, in contrast to superoxide dismutase. CONCLUSIONS These results suggest that the suppression of NK cell activity by AM in SM may be caused by O2- release rather than by prostaglandins, H2O2 or OH release from AM.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits
D016676 Macrophages, Alveolar Round, granular, mononuclear phagocytes found in the alveoli of the lungs. They ingest small inhaled particles resulting in degradation and presentation of the antigen to immunocompetent cells. Alveolar Macrophages,Macrophages, Pulmonary,Pulmonary Macrophages,Macrophage, Pulmonary,Pulmonary Macrophage,Alveolar Macrophage,Macrophage, Alveolar

Related Publications

M Takeuchi, and S Nagai, and A Nakajima, and M Shinya, and C Tsukano, and H Asada, and K Yoshikawa, and M Yoshimura, and T Izumi
February 1990, Immunological investigations,
M Takeuchi, and S Nagai, and A Nakajima, and M Shinya, and C Tsukano, and H Asada, and K Yoshikawa, and M Yoshimura, and T Izumi
October 1986, The Journal of allergy and clinical immunology,
M Takeuchi, and S Nagai, and A Nakajima, and M Shinya, and C Tsukano, and H Asada, and K Yoshikawa, and M Yoshimura, and T Izumi
August 1982, Journal of immunology (Baltimore, Md. : 1950),
M Takeuchi, and S Nagai, and A Nakajima, and M Shinya, and C Tsukano, and H Asada, and K Yoshikawa, and M Yoshimura, and T Izumi
September 1989, Cancer research,
M Takeuchi, and S Nagai, and A Nakajima, and M Shinya, and C Tsukano, and H Asada, and K Yoshikawa, and M Yoshimura, and T Izumi
August 1986, Cellular immunology,
M Takeuchi, and S Nagai, and A Nakajima, and M Shinya, and C Tsukano, and H Asada, and K Yoshikawa, and M Yoshimura, and T Izumi
July 1984, Arthritis and rheumatism,
M Takeuchi, and S Nagai, and A Nakajima, and M Shinya, and C Tsukano, and H Asada, and K Yoshikawa, and M Yoshimura, and T Izumi
July 1994, Immunology letters,
M Takeuchi, and S Nagai, and A Nakajima, and M Shinya, and C Tsukano, and H Asada, and K Yoshikawa, and M Yoshimura, and T Izumi
May 1985, Journal of the National Cancer Institute,
M Takeuchi, and S Nagai, and A Nakajima, and M Shinya, and C Tsukano, and H Asada, and K Yoshikawa, and M Yoshimura, and T Izumi
June 1980, Journal of immunology (Baltimore, Md. : 1950),
M Takeuchi, and S Nagai, and A Nakajima, and M Shinya, and C Tsukano, and H Asada, and K Yoshikawa, and M Yoshimura, and T Izumi
January 1995, Japanese journal of cancer research : Gann,
Copied contents to your clipboard!